NCT04382144 (LELIBU) is a Phase 4 clinical trial of Liposomal bupivacaine in Tennis Elbow, sponsored by Turku University Hospital.

Who is sponsoring NCT04382144?

NCT04382144 is sponsored by Turku University Hospital.

What drugs are being tested in NCT04382144?

Interventions in NCT04382144: Liposomal bupivacaine.

What condition does NCT04382144 study?

NCT04382144 studies Tennis Elbow, Lateral Epicondylitis.

Is NCT04382144 still recruiting?

NCT04382144 is currently status unknown. Last updated 11 May 2020.

Last reviewed 2020-05-11 · How we verify

NCT04382144: LELIBU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Levobupivacaine Versus Liposomal Bupivacaine (Exparel®) for Treatment of Pain and Disability in Lateral Epicondylitis

Status unknown Phase 4 Last updated 11 May 2020

What this trial tests

Phase 4 trial testing Liposomal bupivacaine in Tennis Elbow in 50 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
31 December 2021

1 May 2022

Quick facts

Lead sponsor	Turku University Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 September 2020
Primary completion	31 December 2021
Estimated completion	1 May 2022

Drugs / interventions tested

Liposomal bupivacaine — full drug profile →

Conditions studied

Tennis Elbow — all drugs for Tennis Elbow →
Lateral Epicondylitis — all drugs for Lateral Epicondylitis →

Sponsor

Turku University Hospital

Who can join

Adults 18 to 65, any sex, with Tennis Elbow or Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the trial is to compare the effectiveness of injected levobupivacaine and liposomal bupivacaine in the treatment of pain and disability in patients with lateral epicondylitis. Primary outcome is pain (VAS) at 1 week and at 1 month after injection. Secondary outcomes are the Quick Disabilities of the Arm, Shoulder and Hand DASH (Quick DASH) and Oxford Elbow Score (OES) and a record of time off work due to lateral epicondylitis in days at 1 week and at 1 month. The study will be a cross-over trial

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Liposomal bupivacaine

Trials testing the same drug.

NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
NCT06575699 — Rectus Sheath Block for Analgesia After Gynecological Laparotomy · Phase 4 · completed
NCT06575010 — Exparel v Dexamethasone in RCR · Phase 4 · enrolling by invitation
NCT06569953 — Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chron · Phase 4 · recruiting
NCT06405724 — Comparison of the Ultrasound-guided Paravertebral Nerve Block With Liposomal Bupivacaine Versus Ropivacaine for Post-Sur · Phase 3 · not yet recruiting

Other recruiting trials for Tennis Elbow

Currently open trials in the same condition.

NCT07406802 — Association Between Racket Stiffness and Lateral Epicondylalgia in Tennis Players · recruiting
NCT07523893 — Comparative Effects of Shockwave Therapy and Eccentric Exercises in Patients With Lateral Epicondylitis · NA · recruiting
NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
NCT07178288 — Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and With · NA · recruiting
NCT07043335 — Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis · NA · recruiting

Other Turku University Hospital trials

Trials by the same sponsor.

NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04382144 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
Last refreshed: 11 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04382144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing